Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001031064 | SCV001194370 | likely pathogenic | Arrhythmogenic right ventricular dysplasia 10 | 2019-07-06 | criteria provided, single submitter | clinical testing | This variant is an in-frame deletion of the genomic region encompassing exon 3 of the DSG2 gene. It preserves the integrity of the reading frame. This variant has not been reported in the literature in individuals with DSG2-related conditions. This variant disrupts the p.Arg49 amino acid residue in DSG2. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 19151369, 28472724). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. |